A Peptide Derived from Endostatin Ameliorates Organ Fibrosis

Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

(2011) Swati Bhattacharyya et al.   MATRIX BIOLOGY

Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin

(2009) Bi Hu et al.   ACTA PHARMACOLOGICA SINICA

Inhibition of Endostatin/Collagen XVIII Deteriorates Left Ventricular Remodeling and Heart Failure in Rat Myocardial Infarction Model

(2009) Kazuya Isobe et al.   CIRCULATION JOURNAL

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

(2009) Angélica M. Santos et al.   JOURNAL OF CLINICAL INVESTIGATION

Transforming growth factor β as a therapeutic target in systemic sclerosis

(2009) John Varga et al.   Nature Reviews Rheumatology

Research Advances of Endostatin and its Short Internal Fragments

(2008) Huan-Li Xu et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis

(2008) A G Richter et al.   THORAX